QRxPharma defendants can access class members’ broker details

Class Actions 2018-09-13 11:49 pm By Miklos Bolza | Sydney

Please login to bookmark

The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au